More than 2,300 black men in the UK could die of prostate cancer over the next ten years if targeted screening programmes are not introduced, experts warn.
Around one in four black men in the UK will face a prostate cancer diagnosis in their lifetime, double the rate experienced by white men, according to recent statistics.
Genetics, limited awareness, delayed medical help, and barriers to diagnostics contribute to the disproportionately high rates of prostate cancer among black men, making early detection a critical health issue.
The government’s National Screening Committee (NSC) recently rejected proposals for targeted prostate cancer screening for high-risk groups, citing insufficient data on black patients and potential harms from widespread testing.
New figures from Prostate Cancer UK reveal that if current rates continue, at least 16,000 men will be diagnosed over the next decade, with thousands likely losing their lives unnecessarily.
Amy Rylance, director of health services, equity and improvement at Prostate Cancer UK, criticized the NSC for failing to utilise existing NHS data to assess risk among black men.
“While we accept the committee’s decision that data gaps exist, this represents a missed opportunity to protect lives, as NHS records could fill these gaps and improve screening decisions,” she said.
The charity is now funding research to analyse NHS health records, aiming to build the evidence base necessary to support targeted screening programmes for black men.
Patients and families have accused the committee of racial bias, arguing that black men are being systematically overlooked despite clear evidence of higher prostate cancer risk.
Jeff Thompson, diagnosed with stage two prostate cancer in 2018, said he felt “as if the government were playing Russian roulette” with black men’s lives after the NSC’s decision.
Thompson described the severe physical and mental impact of his diagnosis and treatment, including erectile dysfunction, urinary problems, and deep emotional trauma that left him isolated and haunted.
“The recovery was brutal and no one prepared me for the mental toll. I felt less of a man, and it was terrifying to face everyday life,” he explained.
He stressed that early detection and support could have prevented much of the suffering he experienced, highlighting the urgent need for targeted prostate cancer programmes.
Tina Davies, whose father Joseph Davies died from stage three prostate cancer in 2011, said black men are “being punished or deemed less valuable” by the lack of targeted screening options.
She explained that black men face the highest risk of prostate cancer, yet screening is denied while the committee claims to promote equity, leaving families frustrated and grieving.
Patients and advocates emphasize that the disparity is preventable, and targeted programmes could save thousands of lives by detecting the disease earlier and providing timely treatment.
Prostate Cancer UK is committed to gathering robust evidence to convince the NSC to implement targeted screening, aiming to protect black men from the disproportionate burden of prostate cancer.
Health experts note that widespread education, awareness campaigns, and accessible screening options are vital to addressing the inequality and encouraging men to seek timely medical advice.
The Department of Health and Social Care stated that screening should be evidence-based and accessible, emphasizing that high-risk groups, including black men, remain a priority for health initiatives.
Rylance reiterated that data gaps must be addressed immediately, with NHS records carefully analysed to demonstrate the benefits of early detection for black men across the UK.
Research and advocacy efforts are expected to deliver results within the next year, potentially creating a framework for implementing effective, targeted prostate cancer screening nationwide.
Critics argue that delays in acting on evidence are costing lives, leaving black men disproportionately affected by a disease that could be detected earlier with appropriate programmes.
Medical professionals highlight that early intervention improves survival rates, reduces treatment complications, and mitigates the emotional and social impact associated with late-stage prostate cancer diagnoses.
The NSC’s consultation process remains open, inviting new evidence to be submitted for review, ensuring that decisions on targeted screening consider the latest data and expert opinions.
Community organisations are urging black men to stay informed, get regular health check-ups, and advocate for expanded access to prostate cancer screening while research continues.
Prostate Cancer UK stresses that every high-risk man counts, and proactive screening, alongside education, can dramatically reduce preventable deaths and improve quality of life for patients.
Patients and families are calling for accountability and transparency from the NSC, arguing that ignoring available evidence reflects a systemic failure to protect vulnerable populations.
As research continues, advocates hope that data-driven recommendations will lead to immediate implementation of targeted programmes to prevent further disproportionate suffering among black men.
“The opportunity to save lives is clear, yet action remains delayed. We must ensure black men are not left behind in cancer prevention policies,” Rylance said.
Health charities emphasize that collective awareness, political will, and robust evidence are key to addressing racial disparities and ensuring equitable healthcare for all men at risk.
Read also: Trump Netanyahu Iran war doubts grow over ‘easy victory’ claims
The debate over targeted prostate cancer screening highlights broader issues of equity, access, and the importance of data-driven health policies to protect the most vulnerable communities.
Experts warn that without urgent change, thousands of black men will continue to die unnecessarily over the next decade, underlining the life-or-death stakes of current policy decisions.
Advocates conclude that combining targeted screening, public education, and research-backed interventions can transform outcomes, reduce preventable deaths, and deliver health equity for black men across the UK.
Are policymakers ready to act decisively, or will black men continue to face disproportionate risk from prostate cancer while critical screening programmes remain delayed?